Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophrenia
Medical Research Council (MR/Y004094/1) and The National Center for Mental Health, funded by the Welsh Government through Health and Care Research Wales. SKL was funded by a PhD studentship from Mental Health Research UK (MHRUK). DBK, JTRW, MCOD and AFP were supported by the European Union's Horizon 2020 research and innovation programme under grant agreement 964874.
Authors
- James Walters (ORCID: https://orcid.org/0000-0002-6980-4053)
- Michael John Owen (ORCID: https://orcid.org/0000-0003-4798-0862)
- Antonio F. Pardiñas (ORCID: https://orcid.org/0000-0001-6845-7590)
- Djenifer B. Kappel (ORCID: https://orcid.org/0000-0002-2906-5911)
- Siobhan K. Lock (ORCID: https://orcid.org/0009-0003-8574-8391)
- Sophie E. Legge (ORCID: https://orcid.org/0000-0001-6617-0289)
- Michael O’Donovan (ORCID: https://orcid.org/0000-0001-7073-2379)
Institutions
- Cardiff University (GB)
- University of Wales (GB)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105745
- Citations
- 3
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.41
Funders
- Mental Health Research UK
- Health and Care Research Wales
- Broad Institute
- European Commission
- Cardiff University
- Medical Research Council
- European Regional Development Fund
- National Center for Mental Health
- National Institute of Mental Health